CLUSTERBODY
Live / Registered — Registered (as of 03 Feb 2026)
What this means for you
Registered since 03 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79425426
- Registration number
- 8122707
- Mark type
- Stylized text
- Filed
- 12 Mar 2025
- Published for opposition
- 16 Dec 2025
- Registered
- 03 Feb 2026
- Attorney of record
- Bradley M. Stohry
Goods and services
- Class 001 — Chemicals: Monoclonal antibodies for scientific purposes.
- Class 005 — Pharmaceuticals: Antibodies for medical purposes; pharmaceutical drugs for the treatment of autoimmune diseases, inflammatory diseases, cancer, allergy, infectious diseases, metabolic disorders, neurological and cardiovascular diseases, fibrotic conditions, and rare or genetic disorders; drugs for medical purposes for the treatment of diseases and disorders related to the immune system, chronic inflammation, cancer, allergy, infectious diseases, metabolic disorders, neurological and cardiovascular diseases, fibrotic conditions, and rare or genetic disorders
- Class 042 — Scientific and technological services: Research and development in the field of biotechnology.
Owner
Prosecution history
- 03 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION
- 10 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Oct 2025 — REFUSAL PROCESSED BY IB
- 16 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 07 Oct 2025 — REFUSAL PROCESSED BY MPU
- 14 Aug 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 13 Aug 2025 — NON-FINAL ACTION WRITTEN
- 12 Aug 2025 — ASSIGNED TO EXAMINER